301509 金凯生科
已收盘 05-18 15:00:00
资讯
新帖
简况
金凯生科：截至2026年5月8日，公司股东数为14,338户
证券之星 · 05-14
金凯生科：截至2026年5月8日，公司股东数为14,338户
金凯生科(301509)5月8日股东户数1.43万户，较上期增加1.12%
证券之星 · 05-13
金凯生科(301509)5月8日股东户数1.43万户，较上期增加1.12%
金凯生科：截至2026年5月8日，公司股东数为14,338户
证券之星 · 05-13
金凯生科：截至2026年5月8日，公司股东数为14,338户
金凯生科：公司核心业务聚焦于含氟医药中间体等小分子CDMO领域
证券之星 · 05-11
金凯生科：公司核心业务聚焦于含氟医药中间体等小分子CDMO领域
金凯生科：截至2026年4月30日，公司股东数为14,179户
证券之星 · 05-07
金凯生科：截至2026年4月30日，公司股东数为14,179户
股市必读：金凯生科（301509）4月28日披露最新机构调研信息
证券之星 · 04-29
股市必读：金凯生科（301509）4月28日披露最新机构调研信息
4月27日金凯生科跌12.65%，富安达健康人生混合A基金重仓该股
证券之星 · 04-27
4月27日金凯生科跌12.65%，富安达健康人生混合A基金重仓该股
金凯生科(301509)4月20日股东户数1.65万户，较上期减少0.08%
证券之星 · 04-24
金凯生科(301509)4月20日股东户数1.65万户，较上期减少0.08%
金凯生科(301509.SZ)发布一季度业绩，归母净利润1664.35万元，下降64.90%
智通财经 · 04-24
金凯生科(301509.SZ)发布一季度业绩，归母净利润1664.35万元，下降64.90%
金凯生科：截至2026年4月20日，公司股东数为16,515户
证券之星 · 04-22
金凯生科：截至2026年4月20日，公司股东数为16,515户
金凯生科：截至2026年4月10日，公司股东数为16,528户
证券之星 · 04-14
金凯生科：截至2026年4月10日，公司股东数为16,528户
金凯生科(301509)3月20日股东户数1.4万户，较上期减少4.64%
证券之星 · 03-30
金凯生科(301509)3月20日股东户数1.4万户，较上期减少4.64%
股市必读：金凯生科（301509）3月18日董秘有最新回复
证券之星 · 03-19
股市必读：金凯生科（301509）3月18日董秘有最新回复
3月11日金凯生科发布公告，股东减持436.89万股
证券之星 · 03-11
3月11日金凯生科发布公告，股东减持436.89万股
金凯生科：截至2026年2月13日，公司股东数为14,635户
证券之星 · 02-25
金凯生科：截至2026年2月13日，公司股东数为14,635户
股市必读：2月13日金凯生科现8笔折价10.01%的大宗交易 合计成交2818.67万元
证券之星 · 02-24
股市必读：2月13日金凯生科现8笔折价10.01%的大宗交易 合计成交2818.67万元
2月13日金凯生科现8笔折价10.01%的大宗交易 合计成交2818.67万元
证券之星 · 02-13
2月13日金凯生科现8笔折价10.01%的大宗交易 合计成交2818.67万元
2月5日金凯生科现202.35万元大宗交易
证券之星 · 02-05
2月5日金凯生科现202.35万元大宗交易
金凯生科：公司储备的临床期项目涉及肿瘤、免疫等多个疾病治疗领域
证券之星 · 01-30
金凯生科：公司储备的临床期项目涉及肿瘤、免疫等多个疾病治疗领域
股市必读：金凯生科（301509）预计2025年全年扣非后净利润盈利7200万元至9100万元
证券之星 · 01-26
股市必读：金凯生科（301509）预计2025年全年扣非后净利润盈利7200万元至9100万元
公司概况
公司名称：
金凯(辽宁)生命科技股份有限公司
所属行业：
医药制造业
上市日期：
2023-08-03
主营业务：
金凯(辽宁)生命科技股份有限公司的主营业务是提供小分子药物中间体以及少量原料药的定制研发生产服务。公司的主要产品是含氟类产品、非含氟类产品。
发行价格：
56.56
{"stockData":{"symbol":"301509","market":"SZ","secType":"STK","nameCN":"金凯生科","latestPrice":32.95,"timestamp":1779087828000,"preClose":33.29,"halted":0,"volume":1627661,"delay":0,"changeRate":-0.0102,"floatShares":56740900,"shares":120000000,"eps":0.6147,"marketStatus":"已收盘","change":-0.34,"latestTime":"05-18 15:00:00","open":33.27,"high":33.48,"low":32.67,"amount":53435400,"amplitude":0.0243,"askPrice":32.95,"askSize":4,"bidPrice":32.91,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.6147,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779154200000},"marketStatusCode":5,"adr":0,"adjPreClose":33.29,"symbolType":"stock","openAndCloseTimeList":[[1779067800000,1779075000000],[1779080400000,1779087600000]],"highLimit":36.62,"lowLimit":29.96,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120446669,"isCdr":false,"pbRate":1.8,"roa":"--","peRate":53.603384,"roe":"0.75%","epsLYR":0.87,"committee":0.453083,"marketValue":3969000000,"turnoverRate":0.0287,"status":1,"floatMarketCap":1870000000},"requestUrl":"/m/hq/s/301509/wiki","defaultTab":"wiki","newsList":[{"id":"2635797824","title":"金凯生科：截至2026年5月8日，公司股东数为14,338户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635797824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635797824?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:48","pubTimestamp":1778748495,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问5月8日的股东人数是多少？金凯生科回复：尊敬的投资者，您好！截至2026年5月8日，公司股东数为14,338户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400029030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635145207","title":"金凯生科(301509)5月8日股东户数1.43万户，较上期增加1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635145207","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635145207?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:32","pubTimestamp":1778664755,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2026年5月8日公司股东户数为1.43万户，较4月30日增加159.0户，增幅为1.12%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至5月8日，医疗服务行业平均股东户数为4.89万户。从股价来看，2026年4月30日至2026年5月8日，金凯生科区间涨幅为1.32%，在此期间股东户数增加159.0户，增幅为1.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300032041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635275803","title":"金凯生科：截至2026年5月8日，公司股东数为14,338户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635275803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635275803?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:34","pubTimestamp":1778643245,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问5月10日的股东户数金凯生科回复：尊敬的投资者，您好！截至2026年5月8日，公司股东数为14,338户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300017729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634019184","title":"金凯生科：公司核心业务聚焦于含氟医药中间体等小分子CDMO领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2634019184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634019184?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:57","pubTimestamp":1778489827,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科05月11日在投资者关系平台上答复投资者关心的问题。公司核心业务聚焦于含氟医药中间体等小分子CDMO领域，具体业务情况请以公司公开披露的信息为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1161","159938","09939","301509","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193910","title":"金凯生科：截至2026年4月30日，公司股东数为14,179户","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193910","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633193910?lang=zh_cn&edition=full","pubTime":"2026-05-07 11:39","pubTimestamp":1778125150,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)05月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月30日公司的股东总数是多少？谢谢金凯生科回复：尊敬的投资者，您好！截至2026年4月30日，公司股东数为14,179户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700015677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631537638","title":"股市必读：金凯生科（301509）4月28日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631537638?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:56","pubTimestamp":1777416991,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，金凯生科报收于35.55元，下跌1.41%，换手率7.55%，成交量4.28万手，成交额1.52亿元。2025年度利润分配方案为每10股派9元，分红比例处于行业高位，基于2025年业绩大幅增长、经营性现金流充裕，并响应监管鼓励分红政策，旨在回报股东长期支持。截至4月28日，最新股东人数以中国证券登记结算有限责任公司深圳分公司下发的4月20日数据为准。关于光气化生产技术的领先地位及竞争情况，具体信息以公司公告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900017178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630366197","title":"4月27日金凯生科跌12.65%，富安达健康人生混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630366197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630366197?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:38","pubTimestamp":1777279129,"startTime":"0","endTime":"0","summary":"证券之星消息，4月27日金凯生科跌12.65%，收盘报36.06元，换手率15.24%，成交量8.65万手，成交额3.14亿元。重仓金凯生科的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为富安达基金的富安达健康人生混合A。富安达健康人生混合A目前规模为0.32亿元，最新净值1.3716，较上一交易日下跌0.77%，近一年上涨11.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700029602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629158812","title":"金凯生科(301509)4月20日股东户数1.65万户，较上期减少0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629158812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629158812?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:44","pubTimestamp":1777023874,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2026年4月20日公司股东户数为1.65万户，较4月10日减少13.0户，减幅为0.08%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至4月20日，医疗服务行业平均股东户数为4.71万户。从股价来看，2026年4月10日至2026年4月20日，金凯生科区间涨幅为0.51%，在此期间股东户数减少13.0户，减幅为0.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400053811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629537816","title":"金凯生科(301509.SZ)发布一季度业绩，归母净利润1664.35万元，下降64.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629537816","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629537816?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:23","pubTimestamp":1777018996,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金凯生科(301509.SZ)发布2026年第一季度报告，该公司营业收入为1.48亿元，同比减少16.01%。归属于上市公司股东的净利润为1664.35万元，同比减少64.90%。归属于上市公司股东的扣除非经常性损益的净利润为1377.58万元，同比减少67.63%。基本每股收益为0.14元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"金凯生科(301509.SZ)发布一季度业绩，归母净利润1664.35万元，下降64.90%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629280013","title":"金凯生科：截至2026年4月20日，公司股东数为16,515户","url":"https://stock-news.laohu8.com/highlight/detail?id=2629280013","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629280013?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:09","pubTimestamp":1776845356,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)04月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问4月20日的股东户数是多少？金凯生科回复：尊敬的投资者，您好！截至2026年4月20日，公司股东数为16,515户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200035931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627467042","title":"金凯生科：截至2026年4月10日，公司股东数为16,528户","url":"https://stock-news.laohu8.com/highlight/detail?id=2627467042","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627467042?lang=zh_cn&edition=full","pubTime":"2026-04-14 09:06","pubTimestamp":1776128797,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)04月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止4月10日，股东户数是多少金凯生科回复：尊敬的投资者，您好！截至2026年4月10日，公司股东数为16,528户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400006604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623213318","title":"金凯生科(301509)3月20日股东户数1.4万户，较上期减少4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623213318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623213318?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:18","pubTimestamp":1774862287,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2026年3月20日公司股东户数为1.4万户，较2月13日减少679.0户，减幅为4.64%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至3月20日，医疗服务行业平均股东户数为4.5万户。从股价来看，2026年2月13日至2026年3月20日，金凯生科区间跌幅为1.58%，在此期间股东户数减少679.0户，减幅为4.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000023398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620926686","title":"股市必读：金凯生科（301509）3月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2620926686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620926686?lang=zh_cn&edition=full","pubTime":"2026-03-19 01:47","pubTimestamp":1773856031,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘，金凯生科报收于38.47元，上涨3.61%，换手率5.63%，成交量3.2万手，成交额1.22亿元。董秘最新回复投资者： 您好，贵公司三季报扣非八千多万利润，年报扣非变成七千多万，那四季变亏损？公司2025年四季度及2025年全年业绩情况请以公司2025年年度报告为准。当日关注点来自交易信息汇总：3月18日主力资金净流入404.14万元，呈现明显吸筹迹象。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900000939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618943289","title":"3月11日金凯生科发布公告，股东减持436.89万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618943289","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618943289?lang=zh_cn&edition=full","pubTime":"2026-03-11 18:01","pubTimestamp":1773223267,"startTime":"0","endTime":"0","summary":"证券之星消息，3月11日金凯生科发布公告《金凯生科:关于股东减持股份计划期间届满暨减持结果的公告》，其股东启鹭(厦门)股权投资合伙企业(有限合伙)、青岛青松创业投资集团有限公司-青岛松凯创业投资企业(有限合伙)于2025年12月26日至2026年3月10日间合计减持436.89万股，占公司目前总股本的3.6272%，变动期间该股股价上涨7.43%，截止3月10日收盘报37.46元。股东增减持详情见下表：根据金凯生科2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100030856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614010267","title":"金凯生科：截至2026年2月13日，公司股东数为14,635户","url":"https://stock-news.laohu8.com/highlight/detail?id=2614010267","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614010267?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:39","pubTimestamp":1772008760,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新一期公司的股东人数是多少？谢谢金凯生科回复：尊敬的投资者，您好！截至2026年2月13日，公司股东数为14,635户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500025882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613703739","title":"股市必读：2月13日金凯生科现8笔折价10.01%的大宗交易 合计成交2818.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613703739","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613703739?lang=zh_cn&edition=full","pubTime":"2026-02-24 02:09","pubTimestamp":1771870151,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，金凯生科报收于39.86元，上涨3.05%，换手率10.24%，成交量5.81万手，成交额2.33亿元。交易信息汇总资金流向2月13日主力资金净流入528.34万元，占总成交额2.27%；游资资金净流入776.71万元，占总成交额3.33%；散户资金净流出1305.05万元，占总成交额5.6%。大宗交易2月13日金凯生科发生8笔折价10.01%的大宗交易，合计成交金额2818.67万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400007430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611913710","title":"2月13日金凯生科现8笔折价10.01%的大宗交易 合计成交2818.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611913710","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611913710?lang=zh_cn&edition=full","pubTime":"2026-02-13 17:23","pubTimestamp":1770974606,"startTime":"0","endTime":"0","summary":"证券之星消息，2月13日金凯生科发生大宗交易，交易数据如下：近三个月该股共发生29笔大宗交易，合计成交2.4万手，折价成交29笔。该股近期无解禁股上市。截至2026年2月13日收盘，金凯生科(301509)报收于39.86元，上涨3.05%，换手率10.24%，成交量5.81万手，成交额2.33亿元。该股近半年内有股东持股变动，合计净减持419.44万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300027526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609432019","title":"2月5日金凯生科现202.35万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2609432019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609432019?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:27","pubTimestamp":1770283628,"startTime":"0","endTime":"0","summary":"证券之星消息，2月5日金凯生科发生大宗交易，交易数据如下：大宗交易成交价格35.5元，相对当日收盘价折价7.74%，成交5.7万股，成交金额202.35万元，买方营业部为国投证券股份有限公司河源分公司，卖方营业部为中国中金财富证券有限公司北京建国门外大街证券营业部。近三个月该股共发生11笔大宗交易，合计成交9290.0手，折价成交11笔。截至2026年2月5日收盘，金凯生科报收于38.48元，上涨5.89%，换手率18.11%，成交量10.28万手，成交额4.01亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500027975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607091073","title":"金凯生科：公司储备的临床期项目涉及肿瘤、免疫等多个疾病治疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2607091073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607091073?lang=zh_cn&edition=full","pubTime":"2026-01-30 15:27","pubTimestamp":1769758033,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问：董，你好。你们带电棒的时候说你们手握几个临床资源。请问你们这个说的临床资源是包含哪些疾病的？最新进展如何？金凯生科回复：尊敬的投资者，您好！公司储备的临床期项目涉及肿瘤、免疫等多个疾病治疗领域，公司会严格按照信息披露规则披露项目信息。由于临床期项目到获批上市仍具有较大不确定性，所以请您关注相关投资风险。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000020472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606883265","title":"股市必读：金凯生科（301509）预计2025年全年扣非后净利润盈利7200万元至9100万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606883265","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606883265?lang=zh_cn&edition=full","pubTime":"2026-01-26 02:45","pubTimestamp":1769366712,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，金凯生科报收于38.92元，上涨0.0%，换手率6.17%，成交量3.5万手，成交额1.36亿元。来自：金凯生科预计2025年度归属净利润同比增长138.28%至200.45%，主要受益于终端需求回暖与毛利率提升。金凯生科发布业绩预告，预计2025年全年归属净利润盈利9200万元至1.16亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779137018515,"stockEarnings":[{"period":"1week","weight":-0.0731},{"period":"1month","weight":-0.26},{"period":"3month","weight":-0.1734},{"period":"6month","weight":-0.0973},{"period":"1year","weight":0.0083},{"period":"ytd","weight":-0.0246}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0198},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0468},{"period":"1year","weight":0.2269},{"period":"ytd","weight":0.041}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金凯(辽宁)生命科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14338人(较上一季度增加1.12%)","perCapita":"3957股","listingDate":"2023-08-03","address":"辽宁省阜新市阜新蒙古族自治县伊吗图镇氟化工园区安仁路6号","registeredCapital":"12044万元","survey":" 金凯(辽宁)生命科技股份有限公司的主营业务是提供小分子药物中间体以及少量原料药的定制研发生产服务。公司的主要产品是含氟类产品、非含氟类产品。","listedPrice":56.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金凯生科,301509,金凯生科股票,金凯生科股票老虎,金凯生科股票老虎国际,金凯生科行情,金凯生科股票行情,金凯生科股价,金凯生科股市,金凯生科股票价格,金凯生科股票交易,金凯生科股票购买,金凯生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}